The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Corient Private Wealth LP lifted its holdings in Cencora, Inc. (NYSE: COR) by 102.9% during the seco

Cencora, Inc. (COR) Presents at 2026 Global Healthcare Conference Transcript

Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Bank of America Corp DE purchased a new position in shares of Cencora, Inc. (NYSE: COR) during the s

AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a

Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.79% on an annualized basi

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

RBC Capital analyst Ryan Halsted reiterates Cencora (NYSE:COR) with a Sector Perform and maintain

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Cencora's specialty momentum, OneOncology growth and GLP-1 volumes offer upside, but drug-price cuts

Cencora (COR) reported earnings 30 days ago. What's next for the stock?

COR launches CGT Enablement to help health systems build and scale cell and gene therapy programs wi

Cencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth des

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora today launched a service to help health systems evaluate

Connor Clark and Lunn Investment Management Ltd. acquired a new stake in shares of Cencora, Inc. (NY

Walmart agreed to pay $50 million to settle a DOJ lawsuit alleging its pharmacies unlawfully filled

Invesco Discovery Mid Cap Growth Fund had a positive return and outperformed its benchmark in the se

Advisors Capital Management LLC purchased a new stake in shares of Cencora, Inc. (NYSE: COR) in the

Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.61% on an annualized basi

RBC Capital analyst Ryan Halsted initiates coverage on Cencora (NYSE:COR) with a Sector Perform r

These healthcare companies can actually benefit from inflation.

Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basi

Beginning July 1, 2026, certain Walgreens volume that was being serviced by Cencora, Inc. (the "

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Shares of Cencora, Inc. (NYSE: COR - Get Free Report) have been assigned a consensus recommendation

Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Overweight and raises the

Morgan Stanley analyst Erin Wright maintains Cencora (NYSE:COR) with a Overweight and raises the

JP Morgan analyst Lisa Gill maintains Cencora (NYSE:COR) with a Overweight and raises the price t

Weak U.S. jobs data boosts hopes for a Fed pause, sending AI chip stocks and other high-beta tech na

Evercore ISI Group analyst John Belton maintains Cencora (NYSE:COR) with a Outperform and raises

Cencora beats third-quarter earnings and revenue estimates, raised fiscal 2026 EPS guidance and main

Cencora (NYSE:COR) raises FY2026 Adj EPS guidance from $17.70-$17.90 to $17.75-$17.95 vs $17.79 anal

Cencora (NYSE:COR) reported quarterly earnings of $4.48 per share which beat the analyst consensus e

B of A Securities analyst Michael Funk maintains Cencora (NYSE:COR) with a Neutral and raises the

Barclays analyst Glen Santangelo maintains Cencora (NYSE:COR) with a Overweight and lowers the pr

The battle between Amazon.com and Walmart has produced a new leader for the Fortune 500 list for 202

CONSHOHOCKEN, Pa. [June 2, 2026] — Cencora today announced an agreement with Kite , a Gilead Company

Cencora, Inc. (NYSE:COR) today announced Eva C. Boratto has been appointed Executive Vice President

Cencora, Inc. (NYSE:COR) today updated its fiscal year 2026 financial guidance as a result of recent

Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Overweight and lowers the

Citigroup analyst Daniel Grosslight maintains Cencora (NYSE:COR) with a Buy and lowers the price

Evercore ISI Group analyst John Belton maintains Cencora (NYSE:COR) with a Outperform and lowers

Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and lowers the price t

Cencora stock falls after Q2 earnings miss and lower sales guidance, despite raising EPS outlook and

U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.

Cencora (NYSE:COR) raises FY2026 Adj EPS guidance from $17.45-$17.60 to $17.65-$17.90 vs $17.60 anal